secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001437749-23-019610
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen CFO Jerrold D. Dotson to retire by Aug 31, 2023; successor identified
------------------------------------------------------------------------------

- CFO Jerrold D. Dotson intends to retire on or about August 31, 2023.
- Retirement not due to any disagreement with the company on operations or policies.
- Board has identified a potential successor, subject to completion of onboarding activities.
- Company will announce successor upon appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000143774923019610/0001437749-23-019610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000143774923019610/vtgn20230706_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-019610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer